First Allied Advisory Services’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-11,174
Closed -$150K 1200
2018
Q4
$150K Sell
11,174
-2,543
-19% -$42.9K 0.01% 992
2018
Q3
$268K Buy
13,717
+157
+1% +$3.34K 0.01% 962
2018
Q2
$347K Sell
13,560
-141
-1% -$3.29K 0.01% 820
2018
Q1
$273K Buy
13,701
+271
+2% +$6.32K 0.01% 910
2017
Q4
$269K Buy
13,430
+1,380
+11% +$27.1K 0.01% 923
2017
Q3
$250K Sell
12,050
-298
-2% -$5.04K 0.01% 898
2017
Q2
$183K Buy
+12,348
New +$206K 0.01% 1054

Other funds holding DPLO

First Allied Advisory Services's DPLO Position: Q1 2019 in Review

First Allied Advisory Services sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 11,174 shares — an estimated $150K sold.

First Allied Advisory Services first reported a position in DPLO in Q2 2017 and held it in 7 quarters. The position peaked at $347K in Q2 2018. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • First Allied Advisory Services reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
  • First Allied Advisory Services sold 11,174 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $150K.
  • First Allied Advisory Services first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2017 and held it in 7 quarters.
  • First Allied Advisory Services's DIPLOMAT PHARMACY, INC. position peaked at $347K in Q2 2018.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on First Allied Advisory Services's 13F filing for Q1 2019, filed 6 May 2019.